test

Scott Smith

Acuta Capital Partners, Llc

Assets Managed
$141.758M
Holdings
26
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-3.75%(2Q avg: 24.23%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Acuta Capital Partners, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 26 positions.

Assets under management

The assets under management (AUM) of Acuta Capital Partners, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 141.758M in assets, with a quarterly growth rate of -3.75% and a 2-quarter average growth rate of 24.23%. The portfolio is managed by Scott Smith, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
PRAX
Praxis Precision Medicines I
Recent Activity
Increased 2.25%
19.3%
$27.354M
84,901 shares@ $322.19 avg price
TERN
Terns Pharmaceuticals Inc
Recent Activity
Decreased -22.18%
18.44%
$26.137M
495,772 shares@ $52.73 avg price
AADI
Aadi Bioscience Inc
Recent Activity
8.3%
$11.766M
3.41M shares@ $3.46 avg price
TNGX
Tango Therapeutics Inc
Recent Activity
Increased 56.28%
6.53%
$9.243M
441,831 shares@ $20.93 avg price
DRUG
Bright Minds Biosciences Inc
Recent Activity
Increased 32.58%
5.77%
$8.172M
111,996 shares@ $72.97 avg price
STRO
Sutro Biopharma Inc
Recent Activity
Increased 299.44%
4.74%
$6.711M
269,425 shares@ $24.92 avg price
ERAS
Erasca Inc
Recent Activity
New Position
4.05%
$5.737M
354,575 shares@ $16.19 avg price
SRZN
Surrozen Inc
Recent Activity
Decreased -3.12%
3.56%
$5.035M
172,847 shares@ $29.13 avg price
OCUL
Ocular Therapeutix Inc
Recent Activity
Decreased -43.76%
3.54%
$5.015M
592,108 shares@ $8.48 avg price
CMPX
Compass Therapeutics Inc
Recent Activity
Decreased -22.33%
3.17%
$4.492M
849,076 shares@ $5.29 avg price

1-10 of 26